CNS Pharmaceuticals Announces Pricing of $4.0 Million Public Offering
HOUSTON, TX / ACCESSWIRE / January 29, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) (“CNS” or the “Company”), a biopharmaceutical company
HOUSTON, TX / ACCESSWIRE / January 29, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) (“CNS” or the “Company”), a biopharmaceutical company
The Luxembourg House of Financial Technology (LHoFT) Foundation, a cornerstone of fintech innovation within Luxembourg’s financial sector since 2016, is
The Luxembourg House of Financial Technology (LHoFT) Foundation, a cornerstone of fintech innovation within Luxembourg’s financial sector since 2016, is
ANKARA: Trkiye’s first astronaut, Alper Gezeravci, conducted his ninth experiment Monday on the International Space Station (ISS).
The study is
ANKARA: Farmers continued blocking the highways around France’s capital on Tuesday to protest the government’s agricultural policies and EU regulations,
ISTANBUL: BRICS member states understand that political processes in finding a settlement in Ukraine are impossible without Moscow’s participation, a
ISTANBUL: Thousands of officials, including high-ranking officers, faced disciplinary action for alleged corruption in China last year, the Daily South
ISTANBUL: The West has understood that the ‘Ukraine project’ has started failing, Russian Foreign Minister Sergey Lavrov said on Tuesday,
ISTANBUL: China’s President Xi Jinping on Tuesday received ambassadorial credentials from the new Afghan envoy to Beijing appointed by the